Today's noteworthy initiations include: 21st Century Fox (FOXA) initiated with an Outperform at Credit Suisse... Actavis (ACT) initiated with an Outperform at Raymond James... Akorn (AKRX) initiated with an Outperform at Raymond James... Amphastar (AMPH) initiated with a Strong Buy at Raymond James... Apollo Global (APO) initiated with an Overweight at Piper Jaffray... Ares Management (ARES) initiated with a Neutral at Credit Suisse... Arista Networks (ANET) initiated with a Buy at Nomura... Artisan Partners (APAM) initiated with a Neutral at Credit Suisse... BlackRock (BLK) initiated with a Neutral at Piper Jaffray... Blackstone (BX) initiated with an Overweight at Piper Jaffray... CBS (CBS) initiated with an Outperform at Credit Suisse... Cablevision (CVC) initiated with an Underperform at Credit Suisse... Caterpillar (CAT) initiated with a Buy at Societe Generale... Charles Schwab (SCHW) initiated with an Overweight at Piper Jaffray... Ciena (CIEN) initiated with a Buy at Nomura... Cisco (CSCO) initiated with a Neutral at Nomura... Colliers International (CIGI) initiated with a Sector Performer at CIBC... Comcast (CMCSA) initiated with an Outperform at Credit Suisse... DISH (DISH) initiated with a Neutral at Credit Suisse... Discovery (DISCA) initiated with a Neutral at Credit Suisse... Disney (DIS) initiated with an Outperform at Credit Suisse... E-Trade (ETFC) initiated with a Neutral at Piper Jaffray... Eaton Vance (EV) initiated with a Neutral at Piper Jaffray... Endo (ENDP) initiated with a Market Perform at Raymond James... Expedia (EXPE) initiated with an Overweight at Barclays... F5 Networks (FFIV) initiated with a Neutral at Nomura... Federated Investors (FII) initiated with a Neutral at Piper Jaffray... Franklin Resources (BEN) initiated with a Neutral at Piper Jaffray... HTG Molecular (HTGM) initiated with an Outperform at JMP Securities... Impax (IPXL) initiated with an Underperform at Raymond James... Invesco (IVZ) initiated with an Overweight at Piper Jaffray... Janus Capital (JNS) initiated with an Overweight at Piper Jaffray... Juniper (JNPR) initiated with a Neutral at Nomura... KKR (KKR) initiated with an Overweight at Piper Jaffray... Lannett (LCI) initiated with an Outperform at Raymond James... Legg Mason (LM) initiated with an Overweight at Piper Jaffray... Manchester United (MANU) initiated with an Outperform at Credit Suisse... Manning & Napier (MN) initiated with a Neutral at Credit Suisse... Mylan (MYL) initiated with a Market Perform at Raymond James... Nutrisystem (NTRI) initiated with a Buy at Craig-Hallum... Orchids Paper (TIS) initiated with a Buy at Jefferies... Perrigo (PRGO) initiated with a Market Perform at Raymond James... Priceline (PCLN) initiated with an Equal Weight at Barclays... Sagent Pharmaceuticals (SGNT) initiated with a Strong Buy at Raymond James... T. Rowe Price (TROW) initiated with a Neutral at Piper Jaffray... TD Ameritrade (AMTD) initiated with a Neutral at Piper Jaffray... Talen Energy (TLN) initiated with an Overweight at Barclays... Teva (TEVA) initiated with a Market Perform at Raymond James... Time Warner (TWX) initiated with an Outperform at Credit Suisse... TripAdvisor (TRIP) initiated with an Underweight at Barclays... Viacom (VIAB) initiated with an Outperform at Credit Suisse... Virtus Investment Partners (VRTS) initiated with a Neutral at Credit Suisse... Waddell & Reed (WDR) initiated with a Neutral at Piper Jaffray... Weight Watchers (WTW) initiated with a Hold at Craig-Hallum... WisdomTree (WETF) initiated with an Outperform at Credit Suisse.

Deutsche Bank analyst Brian Bedell lowered the firm's price target on Invesco to $15 from $17 and keeps a Hold rating on the shares. The company reported a "difficult" Q1 with pressure on fee rates and margins, the analyst tells investors in a research note.

Argus analyst Stephen Biggar raised the firm's price target on Blackstone to $135 from $133 and keeps a Buy rating on the shares. The company's Q1 earnings beat benefited from growth in fee-related earnings, while its management has previously laid out a constructive case for a recovery in the commercial real estate market, noting values are bottoming, new construction has declined substantially, and the cost of capital has peaked, the analyst tells investors in a research note. Argus adds that stable to lower interest rates should also improve transaction activity.

TD Cowen lowered the firm's price target on Invesco to $19.50 from $21 and keeps a Buy rating on the shares. The firm said its Q1 report did little to alter the narrative that they can not generate meaningful operating/EPS leverage even as AUM climbs; though Cowen thinks related headwinds should further abate into 2H 2024/2025.

Vanda Pharmaceuticals "announced that the Supreme Court denied Vanda's petition for a writ of certiorari in its HETLIOZ(R) Abbreviated New Drug Application litigation against Teva Pharmaceuticals USA, Inc., Apotex Inc. and Apotex Corp." CEO Mihael H. Polymeropoulos stated: "We are disappointed that the Supreme Court has decided not to hear our case and clarify the lower court standard for obviousness in patent law. However, we are pleased that our case has drawn attention to an area of law that has broad and significant implications in life sciences innovation."

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

The company said, "The Board of Hipgnosis (HPGSF) notes the announcement by Blackstone Europe (BX), acting as sub- advisor to the Blackstone Funds and confirms that it yesterday received an improved proposal to acquire the entire issued and to be issued share capital of Hipgnosis on the terms set out in the Blackstone announcement. The Board, having reviewed the Proposal with its financial adviser, Singer Capital Markets, has indicated to Blackstone that the Proposal is at a value that it would be minded to recommend to its shareholders should Blackstone announce a firm intention to make an offer pursuant to Rule 2.7 of the Code on such financial terms." The statement comes following a Saturday announcement by Hipgnosis, which said, "Blackstone Europe LLP, acting as sub-advisor to the Blackstone Funds notes the recent speculation regarding Hipgnosis. Blackstone confirms that it has made a series of proposals regarding a possible offer for the entire issued and to be issued share capital of Hipgnosis. Blackstone furthermore notes Concord Chorus Limited's firm offer on 18 April 2024 to acquire the entire issued and to be issued share capital of Hipgnosis. Blackstone has made an improved fourth proposal to acquire the entire issued and to be issued share capital of Hipgnosis at a price of $1.24 per share in cash. Should Blackstone announce a firm intention to make an offer for Hipgnosis pursuant to Rule 2.7 of the Code under the terms of the Fourth Proposal, it is intended that such a Firm Offer would be effected by means of a takeover offer as defined in Chapter 3 of Part 28 of the Companies Act 2006. However, Blackstone would reserve the right, pursuant to its rights under the Code to implement any such Firm Offer by way of a scheme of arrangement under Part 26 of the Companies Act 2006 should a Firm Offer be announced." Reference Link